Nailesh Bhatt
CIK 1806525 · last filed 2026-04-02
Nailesh Bhatt is a corporate insider who has filed 11 SEC Form 4 insider transactions across 2 companies since 2020. The most recent filing, for PURR, was dated Apr 2, 2026. Across all open-market trades the lifetime net is +$5.8K, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $394.3K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$394.3K
2
11
$5.8K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| PURR | Director | 45,326 | $8.70 | $394.3K | $0 | 3 | 2026-04-02 |
| Sonnet BioTherapeutics Holdings, Inc. (SONN) Delisted | Director | 0 | $1.26 | $0 | $5.8K | 8 | 2025-12-03 |
Recent Filings
11 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-04-02 | PURR | Grant (A) | +2,455 | $0 | EDGAR |
| 2026-02-11 | PURR | Grant (A) | +40,789 | $0 | EDGAR |
| 2025-12-12 | PURR | Other (J) | +2,082 | $0 | EDGAR |
| 2025-12-03 | Sonnet BioTherapeutics Holdings, Inc. (SONN) Delisted | Disp (D) | −10,547 | $0 | EDGAR |
| 2025-07-15 | Sonnet BioTherapeutics Holdings, Inc. (SONN) Delisted | Grant (A) | +10,000 | $0 | EDGAR |
| 2024-12-05 | Sonnet BioTherapeutics Holdings, Inc. (SONN) Delisted | Grant (A) | +373 | $0 | EDGAR |
| 2023-05-18 | Sonnet BioTherapeutics Holdings, Inc. (SONN) Delisted | Buy (P) | +25,000 | $5.8K | EDGAR |
| 2022-12-22 | Sonnet BioTherapeutics Holdings, Inc. (SONN) Delisted | Grant (A) | +3,770 | $0 | EDGAR |
| 2022-04-08 | Sonnet BioTherapeutics Holdings, Inc. (SONN) Delisted | Grant (A) | +14,152 | $0 | EDGAR |
| 2020-07-02 | Sonnet BioTherapeutics Holdings, Inc. (SONN) Delisted | Grant (A) | +8,005 | $0 | EDGAR |